Braster S.A. Cash Flow Conversion Efficiency
Braster S.A. cash flow conversion efficiency. Based on the latest financial reports, Braster S.A. (BRA) has a cash flow conversion efficiency ratio of -0.048x as of March 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł244.00K ≈ $67.15K USD) by net assets (zł-5.04 Million ≈ $-1.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Braster S.A. (2011–2023)
Cash flow conversion efficiency of Braster S.A. from 2011 to 2023. This chart illustrates how Braster S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View BRA live share price for real-time trading data and today's change.
Braster S.A. Cash Flow Conversion Ratio Explained
Braster S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Braster S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Braster S.A. ranked by their cash flow conversion efficiency. Also see BRA market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TaoWeave Inc.
NASDAQ:TWAV
|
-0.098x |
|
Erika Carmel Ltd
TA:BCUR
|
0.113x |
|
Ravi Kumar Distilleries Limited
NSE:RKDL
|
0.122x |
|
Genesis Resources Ltd
AU:GES
|
-0.764x |
|
MAST ENERGY DEV. LS -001
F:97D
|
N/A |
|
Citatah Tbk
JK:CTTH
|
-0.063x |
|
Asia Pacific Fibers Tbk
JK:POLY
|
-0.005x |
|
Senti Biosciences Inc
NASDAQ:SNTI
|
-1.163x |
Annual Cash Flow Conversion Efficiency for Braster S.A. (2011–2023)
The table below shows the annual cash flow conversion efficiency of Braster S.A. from 2011 to 2023. Review how much free cash does Braster S.A. generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | zł-4.43 Million ≈ $-1.22 Million |
zł1.24 Million ≈ $340.17K |
-0.279x | -114.68% |
| 2022-12-31 | zł650.00K ≈ $178.89K |
zł1.24 Million ≈ $340.17K |
1.902x | +298.59% |
| 2021-12-31 | zł1.76 Million ≈ $485.75K |
zł-1.69 Million ≈ $-465.11K |
-0.958x | -85.29% |
| 2020-12-31 | zł7.90 Million ≈ $2.18 Million |
zł-4.08 Million ≈ $-1.12 Million |
-0.517x | +44.24% |
| 2019-12-31 | zł20.79 Million ≈ $5.72 Million |
zł-19.27 Million ≈ $-5.30 Million |
-0.927x | -55.58% |
| 2018-12-31 | zł29.02 Million ≈ $7.99 Million |
zł-17.28 Million ≈ $-4.76 Million |
-0.596x | -0.48% |
| 2017-12-31 | zł48.80 Million ≈ $13.43 Million |
zł-28.93 Million ≈ $-7.96 Million |
-0.593x | -113.65% |
| 2016-12-31 | zł34.84 Million ≈ $9.59 Million |
zł-9.67 Million ≈ $-2.66 Million |
-0.277x | -74.47% |
| 2015-12-31 | zł42.00 Million ≈ $11.56 Million |
zł-6.68 Million ≈ $-1.84 Million |
-0.159x | -100.80% |
| 2014-12-31 | zł8.81 Million ≈ $2.43 Million |
zł-698.00K ≈ $-192.10K |
-0.079x | +83.70% |
| 2013-12-31 | zł5.92 Million ≈ $1.63 Million |
zł-2.88 Million ≈ $-791.61K |
-0.486x | -102.29% |
| 2012-12-31 | zł8.64 Million ≈ $2.38 Million |
zł-2.07 Million ≈ $-570.99K |
-0.240x | +96.62% |
| 2011-12-31 | zł63.73K ≈ $17.54K |
zł-452.66K ≈ $-124.58K |
-7.103x | -- |
About Braster S.A.
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more